Parkinson’s disease (PD) is the second most common neurodegenerative disorder after Alzheimer’s disease. The present study was undertaken to investigate the pretreatment effects of standardized Ginkgo biloba extract (EGb761®) and low-dose whole-body γ-irradiation on the neurological dysfunction in the reserpine model of PD. Male Wistar rats were pretreated orally with EGb761 or fractionated low-dose whole-body γ-irradiation or their combination, then subjected to intraperitoneal injection of reserpine (5 mg/kg body weight) 24 h after the final dose of EGb761 or radiation. Reserpine injection resulted in the depletion of striatal dopamine (DA) level, increased catalepsy score, increased oxidative stress indicated via depletion of glutathione (GSH), increased malondialdehyde (MDA) and iron levels, decreased DA metabolites metabolizing enzymes; indicated by inhibition by glutathione-S-transferase, and nicotinamide adenine dinucleotide phosphate (NADPH)-quinone oxidoreductase (NQO) activities, mitochondrial dysfunction; indicated by declined complex I activity, and adenosine triphosphate (ATP) level and increased apoptosis; indicated by decreased mitochondrial B cell lymphoma-2 (Bcl-2) protein level and by transmission electron microscope. EGb761 and low-dose γ-radiation ameliorated the reserpine-induced state of oxidative stress, mitochondrial dysfunction, and apoptosis in brain. It can be concluded that EGb761, a widely used herbal medicine and low dose of γ-irradiation have protective effects for combating Parkinsonism possibly via replenishment of GSH levels.
Abdel-KaderRHauptmannSKeilUScherpingILeunerKEckertA. (2007) Stabilization of mitochondrial function by Ginkgo biloba extract (EGb761). Pharmacological Research56: 493–502.
2.
AhlemeyerBKrieglsteinJ (2003) Neuroprotective effects of Ginkgo biloba extract. Cellular and Molecular Life Sciences60: 1779–1792.
3.
AhmadMSaleemSAhmadASYousufSAnsariMAKhanB. (2005) Ginkgo biloba affords dose-dependent protection against 6-hydroxyDA-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences. Journal of Neurochemistry93: 94–104.
4.
AlamMSchmidtWJ (2004) L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats. Behavioural Brain Research153: 439–446.
5.
AminASaifuddinAFlanaganAPattersonDLehovskyJ (2004) Radiotherapy induced malignant peripheral nerve sheath tumor of the cauda equine. Spine29(21): E506–E509.
6.
AndersonMGLibbyRTGouldDBSmithRSJohnSW (2005) High-dose radiation with bone marrow transfer prevents neurodegeneration in an inherited glaucoma. Proceedings of the National Academy of Sciences of the United States of America102: 4566–4571.
7.
BeutlerEDuronOKellyBM (1963) Improved method for the determination of blood glutathione. Journal of Laboratory and Clinical Medicine61: 882–888.
8.
BilskaADubielMSokołowska-JezewiczMLorenc-KociEWłodekL (2007) Alpha-lipoic acid differently affects the reserpine-induced oxidative stress in the striatum and prefrontal cortex of rat brain. Neuroscience146(4): 1758–1771.
9.
BogdándiENBaloghAFelgyinszkiNSzatmáriTPersaEHildebrandtG. (2010) Effects of low dose radiation on the immune system of mice after total-body irradiation. Radiation Research174(4): 480–489.
10.
BotkerHEKimoseHHHelligsoPNielsenTT (1994) Analytical evaluation of high energy phosphate determination by high performance liquid chromatography in myocardial tissue. Journal of Molecular and Cellular Cardiology26: 41–48.
11.
CantarellaGDi BenedettoGMartinezGLoretoCClementiGCantarellaA. (2009) Amylin prevents TRAIL-mediated apoptotic effects of reserpine in the rat gastric mucosa. Peptides30: 1466–1472.
12.
CatravasGNMcHaleCG (1974) Radiation-induced changes in the activity of brain enzymes involved in neurotransmitter metabolism. Radiation Research58(3): 462–469.
13.
ChenDFSchneiderGEMartinouJCTonegawaS (1997) Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature385: 434–439.
14.
ChoiEKTeraiyKJizIMKookzYHParkzKHOhzET. (2007) Upregulation of NAD(P)H: quinone oxidoreductase by radiation potentiates the effect of bioreductive B-lapachone on cancer cells. Neoplasia9(8): 634–642.
15.
ChristenY (2001) The effects of Ginkgo biloba extract (EGb761) on neurodegenerative processes. In: ChristenY (ed) Ginkgo Biloba Extract (EGb 761) as a Neuroprotective Agent: From Basic Studies to Clinical Trials, vol. 8. Advances in Ginkgo biloba Extract Research. Elsevier, Paris, France, pp. 1–13.
16.
CudkowiszMESextonPMEllisTHaydenTLGwiltPRWhalenJ. (1999) The pharmacokinetics and pharmacodynamics of procysteine in amyotropic lateral sclerosis. Neurology52: 1492–1494.
17.
DaveyGPPeuchenSClarkJB (1998) Energy thresholds in brain mitochondria. Potential involvement in neurodegeneration. Journal of Biological Chemistry273: 12753–12757.
18.
DeFeudisFV (1991) Ginkgo Biloba Extract EGb 761: Pharmacological Activities and Clinical Applications. Paris, France: Elsevier, pp. 1–8.
19.
DexterDTWellsFRLeesAJJavoy-AgidFAgidYJennerP. (1989) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson’s disease. Journal of Neurochemistry52: 1830–1836.
20.
DiMarzoVHillMPBisognoTCrossmanARBrotchieJM (2000) Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson’s disease. FASEB Journal14: 1432–1438.
21.
DoubleKLMaywaldMSchmittelMRiedererPGerlachM (1998) In vitro studies of ferritin iron release and neurotoxicity. Journal of Neurochemistry70: 2492–2499.
22.
DoyleAEMcQueenEGSmirkFH (1955) Treatment of hypertension with reserpine, with freserpine in combination with pentapyrollidinium and with reserpine, with freserpine in combination with veratrum alkaloids. Circulation11: 170–181.
23.
EkstrandMITerziogluMGalterDZhuSHofstetterCLindqvistE. (2007) Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proceedings of the National Academy of Sciences of the United States of America104(4): 1325–1330.
24.
FiskumGStarkovAPolsterBMChinopoulosC (2003) Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson’s disease. Annals of the New York Academy of Sciences991: 111–119.
25.
FlierJVan MuiswinkelFLJongenelenCADrukarchB (2002) The neuroprotective antioxidant alpha-lipoic acid induces detoxication enzymes in cultured astroglial cells. Free Radical Research36: 695–699.
26.
FornstedtBBerghIRosengrenECarlssonA (1990) An improved HPLC-electrochemical detection method for measuring brain levels of 5-S-cysteinyldopamine, 5-S-cysteinyl-3,4-dihydroxyphenylalanine, and 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid. Journal of Neurochemistry54: 578–586.
27.
FuentesPParisINassifMCaviedesPSegura-AguilarS (2007) Inhibition of VMAT-2 and DT diaphorase induced cell death in a substantia nigra-derived cell line-an experimental cell model for dopamine toxicity studies. Chemical Research in Toxicology20: 776–783.
28.
GanchevTMilevaVVelikovaMGeorgievaM (1998) Influence of reserpine on iron absorption in rats. Haematologia (Budap)29(1): 33–39.
GottliebEVander HeidenMGThompsonCB (2000) Bcl-x(L) prevents the initial decrease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis. Molecular Cell Biology20: 5680–5689.
31.
GriffithsPDDobsonBRJonesGRClarkeDT (1999) Iron in the basal ganglia in Parkinson’s disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. Brain122: 667–673.
32.
GuoLZhangYLiQ (2009) Spectrophotometric determination of dopamine hydrochloride in pharmaceutical, banana, urine and serum samples by potassium ferricyanide-Fe(III). Analytical Sciences25(12): 1451–1455.
33.
HabigWHPabstMJJakobyWP (1974) Glutathione S-transferases: the first enzymatic step in mercapturic acid formation. Journal of Biological Chemistry249(22): 7130–7139.
34.
HalliwellBGutteridgeJMC (1999) Free Radicals in Biology and Medicine. 3rd ed. New York, NY: Oxford University Press, pp. 645–660.
35.
HealesSJDaviesSEBatesTEClarkJB (1995) Depletion of brain glutathione is accompanied by impaired mitochondrial function and decreased N-acetyl aspartate concentration. Neurochemistry Research20: 31–38.
36.
HochmanASterninHGorodinSKorsmeyerSZivIMelamedE. (1998) Enhanced oxidative stress and altered antioxidants in brains of Bcl-2-deficient mice. Journal of Neurochemistry71: 741–748.
37.
IkushimaTAritomiHMorisitaJ (1996) Radioadaptive response: efficient repair of radiation-induced DNA damage in adapted cells. Mutation Research358: 193–198.
38.
JennerP (1993) Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson’s disease. Acta Neurologica Scandinavica, Supplementum146: 6–13.
39.
KaneDJSarafianTAAntonRHahnHGrallaEBValentineJS. (1993) Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science262: 1274–1277.
40.
KaurSStarrMS (1997) Differential effects of intrastriatal and intranigral injections of glutamate antagonists on motor behaviour in the reserpine-treated rat. Neuroscience76(2): 345–354.
41.
KeyerKImlayJA (1996) Superoxide accelerates DNA damage by elevating free-iron levels. Proceedings of the National Academy of Sciences of the United States of America93: 13635–13640.
42.
KipnisJAvidanHMarkovichYMizrahiTHaubenEPrigozhinaTB. (2004) Low-dose gamma-irradiation promotes survival of injured neurons in the central nervous system via homeostasisdriven proliferation of T cells. European Journal of Neuroscience19: 1191–1198.
43.
KojimaSMatsukiONomuraTYamaokaKTakahashiMNikiE (1999) Elevation of antioxidant potency in the brain of mice by low-dose gamma-ray irradiation and its effect on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced brain damage. Free Radical Biology and Medicine26: 388–395.
44.
KowaltowskiAJFentonRGFiskumG (2004) Bcl-2 family proteins regulate mitochondrial reactive oxygen production and protect against oxidative stress. Free Radical Biology and Medicine37(11): 1845–1853.
45.
KrieglsteinJAusmeierFEl-AbharHLippertKWelschMRupallaK. (1995) Neuroprotective effects of Ginkgo biloba constituents. European Journal of Pharmaceutical Sciences3: 39–48.
46.
LiangYLiSZouQSuB (2006) Potential neuroprotective effect of low dose whole-body gamma-irradiation against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic toxicity in C57 mice. Neuroscience Letters400: 213–217.
47.
LowryOHRosenbroughNJFarrALRandallRJ (1951) Protein measurement with Folin phenol reagent. Journal of Biological Chemistry193: 265–275.
NaiduPSSinghAKaurPSandhirRKulkarniSK (2003) Possible mechanism of action in melatonin attenuation of haloperidol-induced orofacial dyskinesia. Pharmacology Biochemistry and Behavior74: 641–648.
50.
NogamiMHuangJTJamesSJLubinskiJMNakamuraLTMakinodanT (1993) Mice chronically exposed to low dose ionizing radiation possess splenocytes with elevated levels of HSP70 mRNA, HSC70 and HSP72 and with an increased capacity to proliferate. International Journal of Radiation Oncology63: 775–783.
51.
OhizumiYTamaiYImamiyaSAkibaT (2002) Complications following re-irradiation for head and neck cancer. American Journal of Otolaryngology23: 215–221.
52.
OkamotoTOgiwaraHHayashiTMitsuiAKawabeTYodoiJ (1992) Human thioredoxin/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type I by thiol redox control mechanism. International Immunology4: 811–819.
53.
PerezCATongYGuoM (2008) Iron chelators as potential therapeutic agents for Parkinson’s disease. Current Bioactive Compounds4(3): 150–158.
54.
PerryTLYongVW (1986) Idiopathic Parkinson’s disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neuroscience Letters67: 269–274.
55.
RamassamyC (2006) Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. European Journal of Pharmacology545: 51–64.
56.
RamassamyCNaudinBChristenYClostreFCostentinJ (1992) Prevention by Ginkgo biloba extract (EGb 761) and trolox C of the decrease in synaptosomal dopamine or serotonin uptake following incubation. Biochemical Pharmacology44: 2395–2401.
57.
ReznichenkoLKalfonLAmitTYoudimMBMandelSA (2010) Low dosage of rasagiline and epigallocatechin gallate synergistically restored the nigrostriatal axis in MPTP-induced parkinsonism. Neurodegenerative Diseases7(4): 219–231.
58.
RiedererPSoficERauschWDSchmidtBReynoldsGPJellingerK. (1989) Transition metals, ferritin, glutathione, and ascorbic acid in Parkinsonian brains. Journal of Neurochemistry52: 515–520.
59.
RiessOKrugerR (1999) Parkinson’s disease: a multifactorial neurodegenerative disorder. Journal of Neural Transmission Supplement56: 113–125.
60.
SasakiKHattaSWadaKUedaNYoshimuraTEndoT. (2002) Effects of extract of Ginkgo biloba leaves and its constituents on carcinogen-metabolizing enzyme activities and glutathione levels in mouse liver. Life Sciences70: 1657–1667.
61.
SattlerUGAMeyerSSQuennetVHoernerCKnoerzerHFabianC. (2010) Glycolytic metabolism and tumour response to fractionated irradiation. Radiotheraphy and Oncology94: 102–109.
62.
SavittJMDawsonVLDawsonTM (2006) Diagnosis and treatment of Parkinson disease: molecules to medicine. Journal of Clinical Investigation116: 1744–1754.
63.
SchapiraAHVOlanowCW (2004) Neuroprotection in Parkinson disease. Mysteries, myths, and misconceptions. Journal of the American Medical Association291: 358–364.
64.
SchierleCWinogradJM (2004) Radiation-induced brachial plexopathy: review. Complication without a cure. Journal of Reconstructive Microsurgery20: 149–152.
65.
SchlagerJJHoerlBJRiebowJScottDPGasdaskaPScottRE. (1993) Increased NAD(P)H:(quinone-acceptor)oxidoreductase activity is associated with density-dependent growth inhibition of normal but not transformed cells. Cancer Research53: 1338–1342.
66.
SchoenbergS (1986) Descriptive epidemiology of Parkinson’s diseases: distribution and hypothesis formulation. Advances in Neurology45: 277–283.
67.
Segura-AguilarJBaezSWiderstenMWelchCJMannervikB (1997) Human class Mu glutathione transferases, in particular isoenzyme M2-2, catalyze detoxication of the dopamine metabolite aminochrome. Journal of Biological Chemistry272: 5727–5731.
68.
Shukitt-HaleBCareyANJenkinsDRabinBMJosephJA (2007) Beneficial effects of fruit extracts on neuronal function and behavior in a rodent model of accelerated aging. Neurobiology of Aging28(8): 1187–1194.
69.
SlyshenkovVSOmelyanchikSNMoiseenokAGPetushokNEWojtczakL (1999) Protection by pantothenol and beta-carotene against liver damage produced by low-dose gamma radiation. Acta Biochimica Polonica46(2): 239–248.
70.
SmithJVBurdickAJGolikPKhanIWallaceDLuoY (2002) Anti-apoptotic properties of Ginkgo biloba extract EGb 761 in differentiated PC12 cells. Cell and Molecular Biology (Noisy-le-grand)48: 699–707.
71.
SoficELangeKWJellingerKRiedererP (1992) Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson’s disease. Neuroscience Letters142: 128–130.
72.
SoficEPaulusWJellingerKRiedererPYoudimMB (1991) Selective increase of iron in substantia nigra zona compacta of Parkinsonian brains. Journal of Neurochemistry56: 978–982.
73.
SoficERiedererPHeinsenHBeckmannHReynoldsGPHebenstreitG. (1988) Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. Journal of Neural Transmission74: 199–205.
74.
SpillantiniMGSchmidtMLLeeVMTrojanowskiJQJakesRGoedertM (1997) Alpha-synuclein in Lewy bodies. Nature388: 839–840.
75.
SuzukiMAmanoMChoiJParkHJWilliamsBOnoK. (2006) Synergistic effects of radiation and b-lapachone in DU-145 human prostate cancer cells in vitro. Radiation Research165: 525–531.
76.
TendiEABosettiFDasguptaSFStellaAMDrieuKRapoportSI (2002) Ginkgo biloba extracts EGb761 and bilobalide increase NADH dehydrogenase mRNA level and mitochondrial respiratory control ratio in PC12 cells. Neurochemistry Research27: 319–323.
77.
UchiyamaMMiharaM (1978) Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Analytical Biochemistry86(1): 271–278.
78.
van MuiswinkelFLRiemersFMPetersGJLaFleurMVSiegelDJongenelenCA. (2000) L-Dopa stimulates expression of the antioxidant enzyme NAD(P)H: quinone oxidoreductase (NQO) in cultured astroglial cells. Free Radical Biology and Medicine29: 442–453.
79.
WaldmeierPCTattonWG (2004) Interrupting apoptosis in neurodegenerative disease: potential for effective therapy?. Drug Discovery Today9(5): 210–218.
80.
WhitfieldCDBostedorRGoodrumDHaakMChuEH (1981) Hamster cell mutants unable to grow on galactose and exhibiting an overlapping complementation pattern are defective in the electron transport chain. Journal of Biological Chemistry256(13): 6651–6656.
81.
WuWRZhuXZ (1999) Involvement of monoamine oxidase inhibition in neuroprotective and neurorestorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice. Life Sciences65(2): 157–164.
82.
YonezawaMMisonohJHosokawaY (1996) Two types of X-ray-induced radioresistance in mice: presence of 4 dose ranges with distinct biological effects. Mutation Research358: 237–243.
83.
YoritakaAHattoriNUchidaKTanakaMStadtmanERMizunoY (1996) Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proceedings of the National Academy of Sciences of the United States of America93: 2696–2701.
84.
YoshitakeTYoshitakeSKehrJ (2010) The Ginkgo biloba extract EGb 761(R) and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex. British Journal of Pharmacology159(3): 659–668.
85.
ZhaoHXucSWangZLiYGuoWLinaC. (2010) Repetitive exposures to low-dose X-rays attenuate testicular apoptotic cell death in streptozotocin-induced diabetes rats. Toxicology Letters192: 356–364.
86.
ZhangYLiSLiangYWenCGuoQSuB (2009) Potential mechanisms of neuroprotection induced by low dose total-body γ-irradiation in C57 mice administered with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neuroscience Letters450: 106–110.
